SKOKIE, Ill.—Integrated DNA Technologies (IDT) announced in February that it had completed, through its Singapore subsidiary, its acquisition of GeneWorks Pty Ltd.’s oligonucleotide manufacturing business in Australia. The deal expands IDT’s footprint and sales options within the Asia-Pacific region, and as a leader in custom nucleic acid synthesis, IDT can provide GeneWorks customers with a variety of manufacturing options for oligos and other high-quality products for genomics research. Following the transaction, GeneWorks will continue to provide molecular and cell biology products and associated services.

 

“With this acquisition, we are furthering our goal of making our world-class products and services more easily accessible to scientists around the world. We look forward to availing GeneWorks’ customers of our unrivaled manufacturing capabilities, design expertise and fast turnaround times,” remarked Dr. Joseph A Walder, founder and CEO of IDT.